Why is Indo US Bio-Tech falling/rising?

As of 17-Sep, Indo US Bio-Tech Ltd's stock price is currently at Rs 142.10, reflecting a decrease of Rs 0.95 or 0.66%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 5.24% during this period. It is also trading lower than its moving averages across various time frames, indicating a bearish trend. The stock is close to its 52-week low, just 3.17% above Rs 137.6. Despite these negative movements, the company has shown strong operational performance with a high return on capital employed (ROCE) of 25.53% and a low debt-to-EBITDA ratio of 0.80 times, suggesting a solid ability to service its debt. Additionally, the company has reported positive results for the last five consecutive quarters, with significant growth in profit after tax and net sales. Broader market context indicates that Indo US Bio-Tech has significantly underperformed compared to the benchmark, with a one-year return of -57.23% against the BSE500's decline of only -2.63%. This stark contrast highlights the stock's struggles relative to the broader market, which has seen positive returns in the last month and year. While there has been a notable increase in investor participation, as evidenced by a 554.58% rise in delivery volume, the overall sentiment remains negative due to the stock's substantial losses over the past year. The combination of underperformance against the market and recent price declines suggests that investor confidence may be waning, contributing to the stock's current downward trajectory.